Review: taking Atenolol and Chromium picolinate together


Summary

Drug interactions are reported among people who take Atenolol and Chromium picolinate together. This review analyzes the effectiveness and drug interactions between Atenolol and Chromium picolinate. It is created by eHealthMe based on reports of 65 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Atenolol

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. (latest outcomes from Atenolol 111,686 users)

Chromium Picolinate

Chromium picolinate has active ingredients of chromium. It is often used in supplementation therapy. (latest outcomes from Chromium picolinate 462 users)

On Sep, 18, 2016

65 people who take Atenolol, Chromium Picolinate are studied.


Number of reports submitted per year:

Atenolol and Chromium picolinate drug interactions.

Drug effectiveness over time:

Atenolol:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Chromium Picolinate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Atenolol:
  • female: 66.0% - (2 of 3 people)
  • male: 0.0% - (0 of 0 people)
Chromium Picolinate:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Atenolol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Chromium Picolinate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • encephalopathy
  • atrial fibrillation
  • hypotension
1 - 6 months:
  • abdominal obesity
  • arthritis
  • back pain - low
  • buffalo hump
  • cervical spinal stenosis
  • degenerative joint disease
  • difficulty in walking
  • early morning joint stiffness
  • edema
  • fatigue
1 - 2 years:
  • backache
  • chronic pancreatitis
  • epilepsy
  • generalised anxiety disorder
  • major depression
  • migraine without aura
  • pain - neck
  • tension headaches
  • trigeminal neuralgia
2 - 5 years:
  • abdominal obesity
  • arthritis
  • back pain - low
  • buffalo hump
  • cervical spinal stenosis
  • degenerative joint disease
  • difficulty in walking
  • early morning joint stiffness
  • edema
  • fatigue
5 - 10 years:
  • backache
  • chronic pancreatitis
  • epilepsy
  • generalised anxiety disorder
  • major depression
  • migraine without aura
  • pain - neck
  • tension headaches
  • trigeminal neuralgia
  • electrocardiogram qt prolonged
not specified:
  • arthralgia
  • fatigue
  • nausea
  • brain oedema
  • drug ineffective
  • gait disturbance
  • lactic acidosis
  • multi-organ failure
  • pain in extremity
  • pancreatitis acute

Most common drug interactions by gender *:

female:
  • fatigue
  • arthralgia
  • gait disturbance
  • joint swelling
  • pain in extremity
  • tension headaches
  • fall
  • hypoaesthesia
  • muscle spasms
  • paraesthesia
male:
  • nausea
  • brain oedema
  • lactic acidosis
  • multi-organ failure
  • pancreatitis acute
  • sepsis
  • shock
  • fatigue
  • acute respiratory distress syndrome
  • acute respiratory failure

Most common drug interactions by age *:

20-29:
  • electrocardiogram qt prolonged
40-49:
  • abdominal obesity
  • arthritis
  • back pain - low
  • buffalo hump
  • cervical spinal stenosis
  • degenerative joint disease
  • difficulty in walking
  • early morning joint stiffness
  • edema
  • fatigue
50-59:
  • brain oedema
  • lactic acidosis
  • multi-organ failure
  • nausea
  • pancreatitis acute
  • sepsis
  • shock
  • arthralgia
  • acute respiratory distress syndrome
  • acute respiratory failure
60+:
  • fatigue
  • feeling abnormal
  • gait disturbance
  • arthralgia
  • drug ineffective
  • headache
  • hypoaesthesia
  • malaise
  • muscle spasms
  • pain in extremity

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Atenolol and Chromium picolinate?

Can you answer these questions?

More questions for: Atenolol, Chromium picolinate

You may be interested in these reviews

More reviews for: Atenolol, Chromium picolinate

On eHealthMe, Atenolol (atenolol) is often used to treat high blood pressure. Chromium picolinate (chromium) is often used to treat supplementation therapy. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.